How often is patent foramen ovale an innocent bystander?. Issue 12 (26th October 2017)

• Record Type: Journal Article
• Authors: Versaci, Francesco; Vizzari, Giampiero; Sergi, Domenico; Andò, Giuseppe; Trivisonno, Antonio; Romeo, Francesco
• Is Part Of: Clinical case reports. Volume 5:Issue 12(2017)
• Page Start: 1992
• Page End: 1994
• Publication Date: 2017-10-26
• Subjects: Brugada syndrome -- palpitations -- patent foramen ovale -- PFO closure -- presyncope; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.1237
• Languages: English
• ISSNs: 2050-0904

Abstract

Key Clinical Message: Patent foramen ovale (PFO) is a risk factor for cryptogenetic stroke; its closure should be considered in selected patients. It is not always clear whether symptoms (presyncope, paresthesia) apparently due to paradoxical embolism are related with other cardiovascular disorders such as arrhythmias. Flecainide administration for post‐PFO‐closure supraventricular arrhythmias can unmask a latent undiagnosed Brugada syndrome. Abstract : Patent foramen ovale (PFO) is a risk factor for cryptogenetic stroke; its closure should be considered in selected patients. It is not always clear whether symptoms (presyncope, paresthesia) apparently due to paradoxical embolism are related with other cardiovascular disorders such as arrhythmias. Flecainide administration for post‐PFO‐closure supraventricular arrhythmias can unmask a latent undiagnosed Brugada syndrome.